Silver Spring, Maryland–(ENEWSPF)–April 16, 2015. The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).
FDA Approves First Generic Copaxone to Treat Multiple Sclerosis
More in Health and Fitness:
